Alessandro Blasimme

Cited by

	All	Since 2017
Citations	2234	2012
h-index	24	23
i10-index	39	35

640

320

160

480

201320142015201620172018201920202021202219 45 49 85 111 155 235 327 536 624

Public access

View all

19 articles

2 articles

available

not available

Based on funding mandates

Co-authors

Effy VayenaETH ZurichVerified email at hest.ethz.ch
Marco CanevelliDepartment of Human Neuroscience, Sapienza University, Rome, ItalyVerified email at uniroma1.it
Giuseppe BrunoProfessore Associato, Università "Sapienza", RomaVerified email at uniroma1.it
Matteo CesariWorld Health OrganizationVerified email at who.int
Marcello IencaEPFLVerified email at epfl.ch
"Glenn Cohen" "I.G. Cohen" "I. Glenn...Harvard Law SchoolVerified email at law.harvard.edu
Bastian Greshake TzovarasSenior Researcher @ Alan Turing Institute & Director of Open HumansVerified email at bio.uni-frankfurt.de
Pierre-Luc GermainUniversity & ETH ZürichVerified email at hest.ethz.ch
Pasquale LaiseSenior Director of Single-Cell Systems Biology at DarwinHealth Inc.Verified email at darwinhealth.com
Giulia FragolaUNC at Chapel HillVerified email at med.unc.edu
Paolo MaugeriEuropean Institute of Oncology - University of MilanVerified email at ieo.eu
paola piscopoRicercatore, Istituto Superiore di Sanità, RomaVerified email at iss.it
Annamaria ConfaloniPrimo Ricercatore, Istituto Superiore di SanitàVerified email at iss.it
Giuseppina TalaricoDipartimento di Neurologia e Psichiatria- Università "Sapienza", RomaVerified email at uniroma1.it
Lisa BortolottiProfessor of Philosophy, University of BirminghamVerified email at bham.ac.uk
Alessandro CuomoIEOVerified email at ieo.eu
Tiziana BonaldiTenured Group Leader European Institute of OncologyVerified email at ieo.it
gabriele bucciIRCCS Ospedale San RaffaeleVerified email at hsr.it
Cesar SommerAllogene TherapeuticsVerified email at allogene.com
Stefano CasolaFIRC Institute of Molecular Oncology, IFOMVerified email at ifom.eu

Alessandro Blasimme

ETH Zurich

Verified email at inserm.fr

Bioethics


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Machine learning in medicine: addressing ethical challenges E Vayena, A Blasimme, IG Cohen PLoS medicine 15 (11), e1002689, 2018	328	2018
Explainability for artificial intelligence in healthcare: a multidisciplinary perspective J Amann, A Blasimme, E Vayena, D Frey, VI Madai BMC Medical Informatics and Decision Making 20 (1), 1-9, 2020	257	2020
Digital health: meeting the ethical and policy challenges E Vayena, T Haeusermann, A Adjekum, A Blasimme Swiss medical weekly 148, w14571, 2018	105	2018
Biomedical big data: new models of control over access, use and governance E Vayena, A Blasimme Journal of bioethical inquiry 14 (4), 501-513, 2017	103	2017
Operational definition of active and healthy ageing (AHA): a conceptual framework J Bousquet, D Kuh, M Bewick, T Standberg, J Farrell, R Pengelly, ME Joel, ... The journal of nutrition, health & aging 19 (9), 955-960, 2015	100	2015
Mapping the translational science policy ‘valley of death’ EM Meslin, A Blasimme, A Cambon-Thomsen Clinical and translational medicine 2 (1), 1-8, 2013	87	2013
Health research with big data: Time for systemic oversight E Vayena, A Blasimme Journal of Law, Medicine & Ethics 46 (1), 119-129, 2018	82	2018
Elements of trust in digital health systems: scoping review A Adjekum, A Blasimme, E Vayena Journal of medical Internet research 20 (12), e11254, 2018	74	2018
What's next for COVID-19 apps? Governance and oversight A Blasimme, E Vayena Science 370 (6518), 760-762, 2020	71	2020
Cell reprogramming requires silencing of a core subset of polycomb targets G Fragola, PL Germain, P Laise, A Cuomo, A Blasimme, F Gross, ... PLoS genetics 9 (2), e1003292, 2013	68	2013
Data sharing for precision medicine: policy lessons and future directions A Blasimme, M Fadda, M Schneider, E Vayena Health Affairs 37 (5), 702-709, 2018	66	2018
Open sharing of genomic data: Who does it and why? T Haeusermann, B Greshake, A Blasimme, D Irdam, M Richards, ... PLoS One 12 (5), e0177158, 2017	62	2017
Operational definition of active and healthy aging (AHA): the European innovation partnership (EIP) on AHA reference site questionnaire: Montpellier October 20–21, 2014, Lisbon … J Bousquet, J Malva, M Nogues, LR Mañas, B Vellas, J Farrell, M Bewick, ... Journal of the American Medical Directors Association 16 (12), 1020-1026, 2015	57	2015
Becoming partners, retaining autonomy: ethical considerations on the development of precision medicine A Blasimme, E Vayena BMC Medical Ethics 17 (67), 2016	48	2016
Familial Alzheimer's disease sustained by presenilin 2 mutations: Systematic review of literature and genotype–phenotype correlation M Canevelli, P Piscopo, G Talarico, N Vanacore, A Blasimme, A Crestini, ... Neuroscience & Biobehavioral Reviews 42, 170-179, 2014	45	2014
Regulation of cell-based therapies in Europe: current challenges and emerging issues A Blasimme, E Rial-Sebbag Stem cells and development 22 (S1), 14-19, 2013	42	2013
Big data and dementia: charting the route ahead for research, ethics, and policy M Ienca, E Vayena, A Blasimme Frontiers in medicine 5, 13, 2018	41	2018
Improving the measurement of scientific success by reporting a self-citation index JW Flatt, A Blasimme, E Vayena Publications 5 (3), 20, 2017	38	2017
Democratizing health research through data cooperatives A Blasimme, E Vayena, E Hafen Philosophy & Technology 31 (3), 473-479, 2018	34	2018
Digital contact tracing against COVID-19 in Europe: current features and ongoing developments A Blasimme, A Ferretti, E Vayena Frontiers in Digital Health 3, 61, 2021	29	2021

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors